Debt free dividend paying, Resonance Specialities, part of the IPCA Laboratories group, reported 124% rise in Q3FY26 PAT to Rs.2.51 cr. Promoters hold 54.25%. The stock appears undervalued at Rs.92 compared to its lifetime high of Rs.254 and may see strong re-rating potential.
